Cardiomyopathy Panel

Cardiomyopathy NGS Panel: Keeping Hearts Healthy


The Comprehensive Cardiomyopathy Panel examines 129 genes associated with hereditary cardiomyopathy including hypertrophic cardiomyopathy (HCM) dilated cardiomyopathy (DCM), Left ventricular non-compaction cardiomyopathy (LVNC), and hereditary arrhythmogenic right ventricular cardiomyopathy (ARVC). 

Who should take the test?

Patients with personal or family history of a hereditary cardiomyopathy. Red flags consist of episodes of chest pain, dizziness, fatigue, abnormal heart rate, shortness of breath, swelling of extremities, and weight gain. Cardiomyopathy can affect people of all ages. 

What are the potential benefits?

Patients with hereditary cardiomyopathy can benefit from increased surveillance and preventive steps to help manage their risks. These steps may include lifestyle changes, medications, implantable devices, medical procedures and surgery. If a pathogenic variant is identified, close relatives such as children, siblings, and parents could have up to a 50% risk to also be at increased risk.